aluates Reports

$ 0.0

Automative

Global Neutropenia Biologic Drug Treatment Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-24D5647

Global Neutropenia Biologic Drug Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Neutropenia Biologic Drug Treatment Market Research Report 2025

Code: QYRE-Auto-24D5647

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Sanofi

Kyowa Kirin

Novartis

Pfizer Inc

Baxter International

Cellerant Therapeutics

Enzychem Lifesciences Corporation

Dong-A ST Co., Ltd

Myelo Therapeutics GmbH

Teva Pharmaceutical Industries Ltd

CVS Health

Partner Therapeutics

Neutropenia Biologic Drug Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neutropenia Biologic Drug Treatment Market

The global market for Neutropenia Biologic Drug Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Neutropenia occurs when patients have a low level of neutrophils which is a type of white blood cells.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Neutropenia Biologic Drug Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neutropenia Biologic Drug Treatment.

The Neutropenia Biologic Drug Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neutropenia Biologic Drug Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neutropenia Biologic Drug Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neutropenia Biologic Drug Treatment Market Report

Report Metric	Details
Report Name	Neutropenia Biologic Drug Treatment Market
CAGR	5%
Segment by Type	Filgrastim Pegfilgrastim Lenograstim Lipegfilgrastim Sargramostim
Segment by Application	Retail Pharmacies Hospital Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Novartis, Pfizer, Baxter International, Cellerant Therapeutics, Dong-A ST Co.,Ltd., Myelo Therapeutics GmbH, Sanofi, Teva Pharmaceutical Industries Ltd., Kyowa Kirin, CVS Health, Partner Therapeutics, Enzychem Lifesciences Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neutropenia Biologic Drug Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neutropenia Biologic Drug Treatment Market report?

Ans: The main players in the Neutropenia Biologic Drug Treatment Market are Amgen, Novartis, Pfizer, Baxter International, Cellerant Therapeutics, Dong-A ST Co.,Ltd., Myelo Therapeutics GmbH, Sanofi, Teva Pharmaceutical Industries Ltd., Kyowa Kirin, CVS Health, Partner Therapeutics, Enzychem Lifesciences Corporation

What are the Application segmentation covered in the Neutropenia Biologic Drug Treatment Market report?

Ans: The Applications covered in the Neutropenia Biologic Drug Treatment Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Neutropenia Biologic Drug Treatment Market report?

Ans: The Types covered in the Neutropenia Biologic Drug Treatment Market report are Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim

Recommended Reports

Cancer & Oncology Treatments

Drug Delivery & Therapy

Alzheimer's & Rare Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Filgrastim

1.2.3 Pegfilgrastim

1.2.4 Lenograstim

1.2.5 Lipegfilgrastim

1.2.6 Sargramostim

1.3 Market by Application

1.3.1 Global Neutropenia Biologic Drug Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neutropenia Biologic Drug Treatment Market Perspective (2020-2031)

2.2 Global Neutropenia Biologic Drug Treatment Growth Trends by Region

2.2.1 Global Neutropenia Biologic Drug Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neutropenia Biologic Drug Treatment Historic Market Size by Region (2020-2025)

2.2.3 Neutropenia Biologic Drug Treatment Forecasted Market Size by Region (2026-2031)

2.3 Neutropenia Biologic Drug Treatment Market Dynamics

2.3.1 Neutropenia Biologic Drug Treatment Industry Trends

2.3.2 Neutropenia Biologic Drug Treatment Market Drivers

2.3.3 Neutropenia Biologic Drug Treatment Market Challenges

2.3.4 Neutropenia Biologic Drug Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue

3.1.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue (2020-2025)

3.1.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neutropenia Biologic Drug Treatment Revenue

3.4 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio

3.4.1 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neutropenia Biologic Drug Treatment Revenue in 2024

3.5 Global Key Players of Neutropenia Biologic Drug Treatment Head office and Area Served

3.6 Global Key Players of Neutropenia Biologic Drug Treatment, Product and Application

3.7 Global Key Players of Neutropenia Biologic Drug Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neutropenia Biologic Drug Treatment Breakdown Data by Type

4.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Type (2020-2025)

4.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2026-2031)

5 Neutropenia Biologic Drug Treatment Breakdown Data by Application

5.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Application (2020-2025)

5.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neutropenia Biologic Drug Treatment Market Size (2020-2031)

6.2 North America Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025)

6.4 North America Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neutropenia Biologic Drug Treatment Market Size (2020-2031)

7.2 Europe Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025)

7.4 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size (2020-2031)

8.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Neutropenia Biologic Drug Treatment Market Size (2020-2031)

9.2 Latin America Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025)

9.4 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size (2020-2031)

10.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Neutropenia Biologic Drug Treatment Introduction

11.1.4 Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Neutropenia Biologic Drug Treatment Introduction

11.2.4 Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Neutropenia Biologic Drug Treatment Introduction

11.3.4 Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Baxter International

11.4.1 Baxter International Company Details

11.4.2 Baxter International Business Overview

11.4.3 Baxter International Neutropenia Biologic Drug Treatment Introduction

11.4.4 Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.4.5 Baxter International Recent Development

11.5 Cellerant Therapeutics

11.5.1 Cellerant Therapeutics Company Details

11.5.2 Cellerant Therapeutics Business Overview

11.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Introduction

11.5.4 Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.5.5 Cellerant Therapeutics Recent Development

11.6 Dong-A ST Co.,Ltd.

11.6.1 Dong-A ST Co.,Ltd. Company Details

11.6.2 Dong-A ST Co.,Ltd. Business Overview

11.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Introduction

11.6.4 Dong-A ST Co.,Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.6.5 Dong-A ST Co.,Ltd. Recent Development

11.7 Myelo Therapeutics GmbH

11.7.1 Myelo Therapeutics GmbH Company Details

11.7.2 Myelo Therapeutics GmbH Business Overview

11.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Introduction

11.7.4 Myelo Therapeutics GmbH Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.7.5 Myelo Therapeutics GmbH Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Neutropenia Biologic Drug Treatment Introduction

11.8.4 Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.8.5 Sanofi Recent Development

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Details

11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Introduction

11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.10 Kyowa Kirin

11.10.1 Kyowa Kirin Company Details

11.10.2 Kyowa Kirin Business Overview

11.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Introduction

11.10.4 Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.10.5 Kyowa Kirin Recent Development

11.11 CVS Health

11.11.1 CVS Health Company Details

11.11.2 CVS Health Business Overview

11.11.3 CVS Health Neutropenia Biologic Drug Treatment Introduction

11.11.4 CVS Health Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.11.5 CVS Health Recent Development

11.12 Partner Therapeutics

11.12.1 Partner Therapeutics Company Details

11.12.2 Partner Therapeutics Business Overview

11.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Introduction

11.12.4 Partner Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.12.5 Partner Therapeutics Recent Development

11.13 Enzychem Lifesciences Corporation

11.13.1 Enzychem Lifesciences Corporation Company Details

11.13.2 Enzychem Lifesciences Corporation Business Overview

11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Introduction

11.13.4 Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025)

11.13.5 Enzychem Lifesciences Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Sanofi

Kyowa Kirin

Novartis

Pfizer Inc

Baxter International

Cellerant Therapeutics

Enzychem Lifesciences Corporation

Dong-A ST Co., Ltd

Myelo Therapeutics GmbH

Teva Pharmaceutical Industries Ltd

CVS Health

Partner Therapeutics

List of Tables

Table 1. Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Filgrastim

Table 3. Key Players of Pegfilgrastim

Table 4. Key Players of Lenograstim

Table 5. Key Players of Lipegfilgrastim

Table 6. Key Players of Sargramostim

Table 7. Global Neutropenia Biologic Drug Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Neutropenia Biologic Drug Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Neutropenia Biologic Drug Treatment Market Share by Region (2020-2025)

Table 11. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Neutropenia Biologic Drug Treatment Market Share by Region (2026-2031)

Table 13. Neutropenia Biologic Drug Treatment Market Trends

Table 14. Neutropenia Biologic Drug Treatment Market Drivers

Table 15. Neutropenia Biologic Drug Treatment Market Challenges

Table 16. Neutropenia Biologic Drug Treatment Market Restraints

Table 17. Global Neutropenia Biologic Drug Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Neutropenia Biologic Drug Treatment Market Share by Players (2020-2025)

Table 19. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2024)

Table 20. Ranking of Global Top Neutropenia Biologic Drug Treatment Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Neutropenia Biologic Drug Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Neutropenia Biologic Drug Treatment, Headquarters and Area Served

Table 23. Global Key Players of Neutropenia Biologic Drug Treatment, Product and Application

Table 24. Global Key Players of Neutropenia Biologic Drug Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Neutropenia Biologic Drug Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2020-2025)

Table 28. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2026-2031)

Table 30. Global Neutropenia Biologic Drug Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2020-2025)

Table 32. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2026-2031)

Table 34. North America Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Neutropenia Biologic Drug Treatment Product

Table 52. Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Neutropenia Biologic Drug Treatment Product

Table 57. Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Pfizer Company Details

Table 60. Pfizer Business Overview

Table 61. Pfizer Neutropenia Biologic Drug Treatment Product

Table 62. Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 63. Pfizer Recent Development

Table 64. Baxter International Company Details

Table 65. Baxter International Business Overview

Table 66. Baxter International Neutropenia Biologic Drug Treatment Product

Table 67. Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 68. Baxter International Recent Development

Table 69. Cellerant Therapeutics Company Details

Table 70. Cellerant Therapeutics Business Overview

Table 71. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product

Table 72. Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 73. Cellerant Therapeutics Recent Development

Table 74. Dong-A ST Co.,Ltd. Company Details

Table 75. Dong-A ST Co.,Ltd. Business Overview

Table 76. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product

Table 77. Dong-A ST Co.,Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 78. Dong-A ST Co.,Ltd. Recent Development

Table 79. Myelo Therapeutics GmbH Company Details

Table 80. Myelo Therapeutics GmbH Business Overview

Table 81. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product

Table 82. Myelo Therapeutics GmbH Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 83. Myelo Therapeutics GmbH Recent Development

Table 84. Sanofi Company Details

Table 85. Sanofi Business Overview

Table 86. Sanofi Neutropenia Biologic Drug Treatment Product

Table 87. Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 88. Sanofi Recent Development

Table 89. Teva Pharmaceutical Industries Ltd. Company Details

Table 90. Teva Pharmaceutical Industries Ltd. Business Overview

Table 91. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product

Table 92. Teva Pharmaceutical Industries Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 93. Teva Pharmaceutical Industries Ltd. Recent Development

Table 94. Kyowa Kirin Company Details

Table 95. Kyowa Kirin Business Overview

Table 96. Kyowa Kirin Neutropenia Biologic Drug Treatment Product

Table 97. Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 98. Kyowa Kirin Recent Development

Table 99. CVS Health Company Details

Table 100. CVS Health Business Overview

Table 101. CVS Health Neutropenia Biologic Drug Treatment Product

Table 102. CVS Health Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 103. CVS Health Recent Development

Table 104. Partner Therapeutics Company Details

Table 105. Partner Therapeutics Business Overview

Table 106. Partner Therapeutics Neutropenia Biologic Drug Treatment Product

Table 107. Partner Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 108. Partner Therapeutics Recent Development

Table 109. Enzychem Lifesciences Corporation Company Details

Table 110. Enzychem Lifesciences Corporation Business Overview

Table 111. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product

Table 112. Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2020-2025) & (US$ Million)

Table 113. Enzychem Lifesciences Corporation Recent Development

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

Table 117. Authors List of This Report

List of Figures

Figure 1. Neutropenia Biologic Drug Treatment Picture

Figure 2. Global Neutropenia Biologic Drug Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neutropenia Biologic Drug Treatment Market Share by Type: 2024 VS 2031

Figure 4. Filgrastim Features

Figure 5. Pegfilgrastim Features

Figure 6. Lenograstim Features

Figure 7. Lipegfilgrastim Features

Figure 8. Sargramostim Features

Figure 9. Global Neutropenia Biologic Drug Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Neutropenia Biologic Drug Treatment Market Share by Application: 2024 VS 2031

Figure 11. Retail Pharmacies Case Studies

Figure 12. Hospital Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Neutropenia Biologic Drug Treatment Report Years Considered

Figure 15. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Neutropenia Biologic Drug Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Neutropenia Biologic Drug Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Neutropenia Biologic Drug Treatment Market Share by Players in 2024

Figure 19. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Neutropenia Biologic Drug Treatment Revenue in 2024

Figure 21. North America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Neutropenia Biologic Drug Treatment Market Share by Country (2020-2031)

Figure 23. United States Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Neutropenia Biologic Drug Treatment Market Share by Country (2020-2031)

Figure 27. Germany Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Region (2020-2031)

Figure 35. China Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Neutropenia Biologic Drug Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Neutropenia Biologic Drug Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Amgen Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 53. Baxter International Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 54. Cellerant Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 55. Dong-A ST Co.,Ltd. Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 56. Myelo Therapeutics GmbH Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 57. Sanofi Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 58. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 59. Kyowa Kirin Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 60. CVS Health Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 61. Partner Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 62. Enzychem Lifesciences Corporation Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Biologic Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lymphoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Lymphocytic Leukemia ALL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematological Malignancy Treatment Market Research Report 2025

Global B Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2024

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics Drug Development Market Research Report 2024

Hematological Malignancy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myeloid Cells Targeting Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Febrile Neutropenia Market Research Report 2024

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions